000			02165 a2200637 4500
005			20250515193451.0
264		0	_c20100622
008			201006s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdp481 _2doi
040			_aNLM _beng _cNLM
100	1		_aSeki, R
245	0	0	_aPrognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2010
300			_a833-841 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xmetabolism
650	0	4	_aCyclophosphamide
650	0	4	_aDoxorubicin
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLymphoma, Large B-Cell, Diffuse _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aRituximab
650	0	4	_aS-Phase Kinase-Associated Proteins _xmetabolism
650	0	4	_aSurvival Analysis
650	0	4	_aVincristine
650	0	4	_aYoung Adult
700	1		_aOhshima, K
700	1		_aFujisaki, T
700	1		_aUike, N
700	1		_aKawano, F
700	1		_aGondo, H
700	1		_aMakino, S
700	1		_aEto, T
700	1		_aMoriuchi, Y
700	1		_aTaguchi, F
700	1		_aKamimura, T
700	1		_aTsuda, H
700	1		_aShimoda, K
700	1		_aOkamura, T
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 21 _gno. 4 _gp. 833-841
856	4	0	_uhttps://doi.org/10.1093/annonc/mdp481 _zAvailable from publisher's website
999			_c19277748 _d19277748